| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/21/2023 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 909 | $14.19 | $12.9k | | 03/21/2023 |
| 01/27/2023 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 14.7k | $0.00 | $0 | | 01/27/2023 |
| 01/27/2023 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 24k | $18.40 | $441.6k | | 01/27/2023 |
| 12/31/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 718 | $12.37 | $8.9k | | 12/31/2022 |
| 09/21/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 908 | $14.85 | $13.5k | | 09/21/2022 |
| 06/21/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Payment of Exercise | Common Stock | 3.6k | $12.48 | $45.3k | | 06/21/2022 |
| 01/27/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 17.6k | $14.44 | $254.1k | | 01/27/2022 |
| 01/27/2022 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 10.3k | $0.00 | $0 | | 01/27/2022 |
| 06/21/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Option to Purchase Common Stock | 72.5k | $20.84 | $1.5M | | 06/21/2021 |
| 06/21/2021 | INTERCEPT PHARMACEUTICALS, INC. | ICPT | Grant | Common Stock | 52.2k | $0.00 | $0 | | 06/21/2021 |
| 05/28/2021 | VYNE Therapeutics Inc. | MNLO | Grant | Common Stock | 3k | $3.36 | $10.1k | | 05/28/2021 |
| 03/31/2021 | VYNE Therapeutics Inc. | MNLO | Payment of Exercise | Common Stock | 762 | $6.84 | $5.2k | | 03/31/2021 |
| 02/22/2021 | VYNE Therapeutics Inc. | MNLO | Grant | Common Stock | 29.2k | $0.00 | $0 | | 02/22/2021 |
| 02/22/2021 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 68.2k | $8.33 | $567.8k | | 02/22/2021 |
| 09/08/2020 | VYNE Therapeutics Inc. | MNLO | Purchase | Common Stock | 40k | $1.46 | $58.5k | | 09/08/2020 |
| 05/06/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 250k | $1.95 | $487.5k | | 05/06/2020 |
| 05/06/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Common Stock | 250k | $0.00 | $0 | | 05/06/2020 |
| 03/23/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Common Stock | 50k | $0.00 | $0 | | 03/23/2020 |
| 03/23/2020 | VYNE Therapeutics Inc. | MNLO | Grant | Stock Options | 100k | $3.13 | $313k | | 03/23/2020 |
| 02/14/2020 | PDS Biotechnology Corp | EDGE | Grant | Common Stock | 38.4k | $1.30 | $49.9k | | 02/14/2020 |
| 06/06/2019 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right To Purchase) | 62.7k | $6.39 | $400.7k | | 06/06/2019 |
| 03/15/2019 | PDS Biotechnology Corp | EDGE | Exercise | Restricted Stock Units | 83k | $0.00 | $0 | | 03/15/2019 |
| 08/14/2018 | PDS Biotechnology Corp | EDGE | Grant | Restricted Stock Units | 83k | $0.00 | $0 | | 08/14/2018 |
| 06/19/2018 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right To Purchase) | 166k | $1.10 | $182.6k | | 06/19/2018 |
| 03/01/2018 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right To Purchase) | 50k | $14.98 | $749k | | 03/01/2018 |
| 11/01/2017 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right To Purchase) | 200k | $10.73 | $2.1M | | 11/01/2017 |